Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 77352 [2015-31367]
Download as PDF
<![CDATA[
77352
Federal Register / Vol. 80, No. 239 / Monday, December 14, 2015 / Notices
reviewers following their review of a
draft of the full Guideline, along with a
summary of comments received and
CDC responses.
Dated: December 9, 2015.
Veronica Kennedy,
Acting Executive Secretary, Centers for
Disease Control and Prevention.
[FR Doc. 2015–31375 Filed 12–11–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces, the following meeting of the
aforementioned committee:
Time and Date: 9:00 a.m.–1:00 p.m.,
January 7, 2016 (OPEN).
Place: Teleconference Dial-In
Number: 1–888–395–7561, Participant
Code: 3954121.
Status: The meeting as designated
above will be open to the public.
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury.
The Board of Scientific Counselors
makes recommendations regarding
policies, strategies, objectives, and
priorities; and reviews progress toward
injury prevention goals and provides
evidence in injury prevention-related
research and programs. The Board also
provides advice on the appropriate
balance of intramural and extramural
research, the structure, progress and
performance of intramural programs.
The Board is designed to provide
guidance on extramural scientific
program matters, including the: (1)
Review of extramural research concepts
for funding opportunity
VerDate Sep<11>2014
17:36 Dec 11, 2015
Jkt 238001
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to the funding opportunity
announcements as it relates to the
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios, and (5) review of
program proposals.
Matters for Discussion: The Board of
Scientific Counselors will discuss the
background for development of the CDC
Guideline for Prescribing Opioids for
Chronic Pain (Guideline) and the
formation of the Prescribing Opioids for
Chronic Pain Workgroup (Opioid
Guideline Workgroup). We will be
accepting public comments only related
to the formation of the Opioid Guideline
Workgroup. There will be 30 minutes
allotted for public comments at the end
of the session. All public comments will
be limited to two-minutes per speaker.
CDC is also publishing a related
notice in today’s Federal Register
announcing the opening of a public
comment period on the Guideline itself.
Individuals are given 30 days to provide
comments on the Guideline. Please see
instructions in that notice about
providing comment.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Arlene Greenspan, Dr. P.H, M.P.H., P.T.,
Associate Director for Science, NCIPC,
CDC, 4770 Buford Highway NE.,
Mailstop F–63, Atlanta, Georgia 30341,
Telephone (770) 488–4696.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–31367 Filed 12–11–15; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–R–282 and
CMS–10597]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments must be received by
February 12, 2016.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ___, Room C4–26–05,
DATES:
E:\FR\FM\14DEN1.SGM
14DEN1
]]>Agencies
[Federal Register Volume 80, Number 239 (Monday, December 14, 2015)]
[Notices]
[Page 77352]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31367]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces, the following meeting of the aforementioned
committee:
Time and Date: 9:00 a.m.-1:00 p.m., January 7, 2016 (OPEN).
Place: Teleconference Dial-In Number: 1-888-395-7561, Participant
Code: 3954121.
Status: The meeting as designated above will be open to the public.
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury.
The Board of Scientific Counselors makes recommendations regarding
policies, strategies, objectives, and priorities; and reviews progress
toward injury prevention goals and provides evidence in injury
prevention-related research and programs. The Board also provides
advice on the appropriate balance of intramural and extramural
research, the structure, progress and performance of intramural
programs. The Board is designed to provide guidance on extramural
scientific program matters, including the: (1) Review of extramural
research concepts for funding opportunity announcements; (2) conduct of
Secondary Peer Review of extramural research grants, cooperative
agreements, and contracts applications received in response to the
funding opportunity announcements as it relates to the Center's
programmatic balance and mission; (3) submission of secondary review
recommendations to the Center Director of applications to be considered
for funding support; (4) review of research portfolios, and (5) review
of program proposals.
Matters for Discussion: The Board of Scientific Counselors will
discuss the background for development of the CDC Guideline for
Prescribing Opioids for Chronic Pain (Guideline) and the formation of
the Prescribing Opioids for Chronic Pain Workgroup (Opioid Guideline
Workgroup). We will be accepting public comments only related to the
formation of the Opioid Guideline Workgroup. There will be 30 minutes
allotted for public comments at the end of the session. All public
comments will be limited to two-minutes per speaker.
CDC is also publishing a related notice in today's Federal Register
announcing the opening of a public comment period on the Guideline
itself. Individuals are given 30 days to provide comments on the
Guideline. Please see instructions in that notice about providing
comment.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Arlene Greenspan, Dr. P.H,
M.P.H., P.T., Associate Director for Science, NCIPC, CDC, 4770 Buford
Highway NE., Mailstop F-63, Atlanta, Georgia 30341, Telephone (770)
488-4696.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-31367 Filed 12-11-15; 8:45 am]
BILLING CODE 4163-18-P
